Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Alkem Laboratories Ltd

NSE: ALKEM · BSE: 539523 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹5,274.00
Market cap: ₹63,059 Cr
Revenue (annual): ₹14,712 Cr
Net profit (annual): ₹2,302 Cr
P/E (TTM): 29.2×Sector 50.4×
Promoter holding: 49.70%-1.50% QoQ
FII holding: 10.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Product Launch 2 Management Change 2 Earnings Call 2 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

14 Aug 2026 13:46 IST NSE

Financial Results

Alkem Laboratories Q1 FY27 Results: Net Profit ₹521 Cr, Down 22.0% YoY

Alkem Laboratories Ltd reported revenue from operations of ₹3,740 Cr (+10.9% YoY) and net profit of ₹521 Cr (-22.0% YoY) for Q1 FY27.

Key figure: Net profit ₹521 Cr · -22.0% YoY

Open full results → Read the filing ↗

28 May 2026 13:30 IST BSE

Financial Results

Alkem Laboratories Q4 FY26 Results: Net Profit ₹236.5 Cr, Down 22.7% YoY

Alkem Laboratories Ltd reported revenue from operations of ₹3,603 Cr (+14.6% YoY) and net profit of ₹236.5 Cr (-22.7% YoY) for Q4 FY26.

Key figure: Net profit ₹236.5 Cr · -22.7% YoY

Open full results → Read the filing ↗

28 May 2026 13:25 IST BSE

Financial Results

Alkem Laboratories Q4 FY26 Results: Net Profit ₹251.1 Cr, Down 22.1% YoY

Alkem Laboratories Ltd reported revenue from operations of ₹3,603 Cr (+14.6% YoY) and net profit of ₹251.1 Cr (-22.1% YoY) for Q4 FY26.

Key figure: Net profit ₹251.1 Cr · -22.1% YoY

Open full results → Read the filing ↗